Sleep duration as a risk factor for diabetes incidence in a large U.S. sample.

STUDY OBJECTIVES To explore the relationship between sleep duration and diabetes incidence over an 8- to 10-year follow-up period in data from the First National Health and Nutrition Examination Survey (NHANES I). We hypothesized that prolonged short sleep duration is associated with diabetes and that obesity and hypertension act as partial mediators of this relationship. The increased load on the pancreas from insulin resistance induced by chronically short sleep durations can, over time, compromise beta-cell function and lead to type 2 diabetes. No plausible mechanism has been identified by which long sleep duration could lead to diabetes. DESIGN Multivariate longitudinal analyses of the NHANES I using logistic regression models. SETTING Probability sample (n=8992) of the noninstitutionalized population of the United States between 1982 and 1992. PARTICIPANTS Subjects between the ages of 32 and 86 years. MEASUREMENTS AND RESULTS Between 1982 and 1992, 4.8% of the sample (n=430) were determined by physician diagnosis, hospital record, or cause of death to be incident cases of diabetes. Subjects with sleep durations of 5 or fewer hours (odds ratio = 1.47, 95% confidence interval 1.03-2.09) and subjects with sleep durations of 9 or more hours (odds ratio = 1.52, 95% confidence interval 1.06-2.18) were significantly more likely to have incident diabetes over the follow-up period after controlling for covariates. CONCLUSIONS Short sleep duration could be a significant risk factor for diabetes. The association between long sleep duration and diabetes incidence is more likely to be due to some unmeasured confounder such as poor sleep quality.

[1]  E. van Cauter,et al.  Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. , 2006, Archives of internal medicine.

[2]  E. Cauter,et al.  P326 Experimental suppression of slow wave sleep without change in total sleep time is associated with decreased glucose tolerance and insulin sensitivity, and increased daytime sympathetic activity , 2006 .

[3]  Steven B. Heymsfield,et al.  Short Sleep Duration as a Risk Factor for Hypertension: Analyses of the First National Health and Nutrition Examination Survey , 2006, Hypertension.

[4]  H. Yaggi,et al.  Sleep duration as a risk factor for the development of type 2 diabetes. , 2006, Diabetes care.

[5]  A. Kalsbeek,et al.  Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. , 2006, Endocrinology.

[6]  Rachel Leproult,et al.  HIGHLIGHTED TOPIC Physiology and Pathophysiology of Sleep Apnea Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes , 2022 .

[7]  C. Björkelund,et al.  Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. , 2005, Diabetes care.

[8]  J. Broman,et al.  High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. , 2005, Diabetes care.

[9]  Steven B Heymsfield,et al.  Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. , 2005, Sleep.

[10]  Susan Redline,et al.  Association of sleep time with diabetes mellitus and impaired glucose tolerance. , 2005, Archives of internal medicine.

[11]  K. Spiegel,et al.  Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite , 2004, Annals of Internal Medicine.

[12]  B. Wisse,et al.  The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. , 2004, Journal of the American Society of Nephrology : JASN.

[13]  Gregor Hasler,et al.  The association between short sleep duration and obesity in young adults: a 13-year prospective study. , 2004, Sleep.

[14]  D. Dinges,et al.  Systematic interindividual differences in neurobehavioral impairment from sleep loss: evidence of trait-like differential vulnerability. , 2004, Sleep.

[15]  David P White,et al.  A prospective study of sleep duration and mortality risk in women. , 2004, Sleep.

[16]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[17]  A. Tamakoshi,et al.  Self-reported sleep duration as a predictor of all-cause mortality: results from the JACC study, Japan. , 2004, Sleep.

[18]  A. Kalsbeek,et al.  Autonomic nervous control of white adipose tissue : studies on the role of the brain in body fat distribution , 2005 .

[19]  L. Phillips,et al.  Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment , 2003, Biological Psychiatry.

[20]  Anne Newman,et al.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. , 2003, Diabetes care.

[21]  J. Manson,et al.  A prospective study of self-reported sleep duration and incident diabetes in women. , 2003, Diabetes care.

[22]  W. Eaton.  Epidemiologic evidence on the comorbidity of depression and diabetes. , 2002, Journal of psychosomatic research.

[23]  M. Mcdaniel,et al.  Identifying the links between obesity, insulin resistance and β‐cell function: potential role of adipocyte‐derived cytokines in the pathogenesis of type 2 diabetes , 2002, European journal of clinical investigation.

[24]  G. Chrousos,et al.  Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders. , 2002, Endocrinology and metabolism clinics of North America.

[25]  D. Kripke,et al.  Mortality associated with sleep duration and insomnia. , 2002, Archives of general psychiatry.

[26]  H. Romijn,et al.  Parasympathetic and sympathetic control of the pancreas: A role for the suprachiasmatic nucleus and other hypothalamic centers that are involved in the regulation of food intake , 2001, The Journal of comparative neurology.

[27]  A. Kalsbeek,et al.  Polysynaptic neural pathways between the hypothalamus, including the suprachiasmatic nucleus, and the liver , 2000, Brain Research.

[28]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[29]  D. Skene,et al.  Comparison between subjective and actigraphic measurement of sleep and sleep rhythms , 1999, Journal of sleep research.

[30]  M. Irwin,et al.  Effects of sleep and sleep deprivation on catecholamine and interleukin-2 levels in humans: clinical implications. , 1999, The Journal of clinical endocrinology and metabolism.

[31]  E. van Cauter,et al.  Sleep loss results in an elevation of cortisol levels the next evening. , 1997, Sleep.

[32]  M Ishii,et al.  Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. , 1996, Hypertension.

[33]  M. Bonnet,et al.  We are chronically sleep deprived. , 1995, Sleep.

[34]  D. Makuc,et al.  Statistical issues in analyzing the NHANES I Epidemiologic Followup Study. Series 2: Data evaluation and methods research. , 1994, Vital and health statistics. Series 2, Data evaluation and methods research.

[35]  M. C. Leske,et al.  Comparing self-reported and physician-reported medical history. , 1994, American journal of epidemiology.

[36]  M. Radomski,et al.  Effects of sleep deprivation and exercise on glucose tolerance. , 1993, Aviation, space, and environmental medicine.

[37]  P. Hauri,et al.  Wrist actigraphy in insomnia. , 1992, Sleep.

[38]  W. B. Webb,et al.  Are we chronically sleep deprived , 1975 .